Testing a patient’s own stem-cell treatment for Parkinson’s
Part of Brain & nervous system clinical trials.
This Phase 1 study tests whether an “autologous” (from your own body) iNSC-DAP stem-cell treatment is safe and may help symptoms in Parkinson’s disease. It is designed mainly to check safety, while also watching for signs of improvement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 30 to 85 years old
- You have a confirmed Parkinson’s diagnosis based on accepted criteria
- You have had Parkinson’s for more than 3 years
- Your Parkinson’s stage is mild to moderate (Hoehn and Yahr stage 4 or less when meds are working)
- Your symptoms respond well to levodopa (your improvement score is over 30%)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an injection called XS411CN for people with Parkinson's disease whose current medications are not working as well as before. The goal is to see if it is safe and tolerable.
This trial uses special stem cells (made from skin or blood cells) to replace damaged brain cells in people with Parkinson's. The goal is to see if these cells can improve movement and reduce symptoms.
This trial tests a new cell therapy, NouvNeu001, for people with Parkinson's disease who have had symptoms for at least 4 years and are having trouble with their current medications. The goal is to see if this treatment is safe and can improve motor symptoms that are not well controlled.
This trial tests a new cell therapy called NouvNeu001 for Parkinson's disease. It involves a one-time brain surgery to deliver the treatment, and researchers will check if it's safe and helps with symptoms.
This Phase 1 study tests whether transplanting your own processed cells (from you) is safe and potentially helpful for people with Parkinson’s disease. Participants are carefully selected based on symptom stage, medication stability, brain scans, and depression/mental function tests.
This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.